MintNeuro develops proprietary low-power semiconductor chips designed for minimally-invasive neural implants, with a portfolio of intellectual property underpinning its solutions. Its core product targets scalable, low-power operation to improve efficiency and accessibility of implantable neurology devices. The company has formed strategic partnerships with medical device companies to deploy adaptable systems. Its technology is positioned to address neurological conditions including epilepsy, movement disorders, and cognitive dysfunctions. MintNeuro plans to use the recent funding to expand operations and its R&D sector. The company was founded as a spinout from Imperial College London and is led by CEO Dorian Haci and CTO Timothy Constandinou.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2024